The Model Health Show cover image

TMHS 763 - Dramatically Extend Your Lifespan, Get Stronger, & Heal Faster With Regenerative Medicine - With Dr. Adeel Khan

The Model Health Show

NOTE

Maximizing Muscle with Long-lasting Follow Statin Gene Therapy

A contract resource organization working closely with Health Canada helped gain approval for a phase two study of a gene therapy for sarcopenia using follow statin peptide. Follow statin inhibits myostatin, an enzyme that limits muscle growth, and has a short half life. The gene therapy vector delivers follow statin, maintaining high levels for 18 to 24 months with just one injection. The phase one trial showed reduced biological age, increased muscle, energy, and strength, and a sense of vitality. The goal is to be the first treatment for sarcopenia and eventually be covered by insurance companies.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner